CLINICAL_TRIALS
trial_result
· 2014-08-18
Clinical Trial Update: Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012) [Phase 3]
Summary
Phase 3 long-term safety study of telcagepant (MK-0974) in adults with acute migraine has completed; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2014-08-18